Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Medicina Intensiva|July 13, 2024
Risk factors and outcome of acute kidney injury in critically ill patients with SARS-CoV-2 pneumonia: a multicenter studyIban Oliva, Cristina Ferré, Xavier Daniel, et al.Critical Care (London, England)|December 1, 2011
Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patientsIgnacio Martin-Loeches, Emili Díaz, Loreto Vidaur, et al.Eclinicalmedicine|July 21, 2025
Advocating for the recognition of underlying immunosuppression in critical illnessIgnacio Martin-Loeches, Sascha David, Frédéric Pène, et al.Journal of Medical Virology|August 4, 2023
Effectiveness of prolonged versus standard-course of oseltamivir in critically ill patients with severe influenza infection: A multicentre cohort studyGerard Moreno, Raquel Carbonell, Emili Díaz, et al.The Journal of Infection|January 14, 2012
Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenzaEmili Diaz, Ignacio Martin-Loeches, Laura Canadell, et al.ERJ Open Research|March 15, 2021
Early oseltamivir treatment improves survival in critically ill patients with influenza pneumoniaGerard Moreno, Alejandro Rodríguez, Jordi Sole-Violán, et al.The Journal of Infection|December 26, 2015
Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysisAlejandro H Rodríguez, Francesc X Avilés-Jurado, Emili Díaz, et al.Critical Care (London, England)|September 15, 2009
Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in SpainJordi Rello, Alejandro Rodríguez, Pedro Ibañez, et al.Critical Care (London, England)|February 16, 2021
Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in SpainAlejandro Rodríguez, Manuel Ruiz-Botella, Ignacio Martín-Loeches, et al.Research Square|January 19, 2022
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodiesJeremy Manry, Paul Bastard, Adrian Gervais, et al.Pageof 4